Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francesco Facchinetti, M.D., Ph.D.

Concepts (186)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung44202454344.390 Why?
Lung Neoplasms512024135943.380 Why?
Protein Kinase Inhibitors18202457071.680 Why?
Drug Resistance, Neoplasm13202453421.570 Why?
Lactams, Macrocyclic520193191.470 Why?
Sulfones420184481.160 Why?
Pyrazoles8202420290.950 Why?
Immunotherapy10202447560.920 Why?
Cholangiocarcinoma320245620.890 Why?
Protein-Tyrosine Kinases7202124330.870 Why?
Receptor, Fibroblast Growth Factor, Type 2120242130.860 Why?
Lactams620211590.770 Why?
Antineoplastic Agents112020136980.760 Why?
Pyrimidines7202430480.760 Why?
Mutation182024302660.760 Why?
Proto-Oncogene Proteins7202145280.700 Why?
Receptor Protein-Tyrosine Kinases4202116290.690 Why?
Receptors, Fibroblast Growth Factor120191960.630 Why?
MAP Kinase Kinase Kinases120202520.620 Why?
Acrylamides320222610.620 Why?
Aminopyridines620215800.610 Why?
Thoracic Neoplasms220212690.610 Why?
Hemoptysis120191520.580 Why?
Xenograft Model Antitumor Assays3202436210.580 Why?
Immunomodulation120215490.570 Why?
Carcinoma, Transitional Cell120237990.540 Why?
Pyridines3201728950.530 Why?
Pleural Neoplasms220236120.520 Why?
Proto-Oncogene Proteins B-raf5202420590.500 Why?
Mesothelioma220238110.480 Why?
Aniline Compounds3202210950.470 Why?
Gene Rearrangement7202111480.440 Why?
Tachyphylaxis12013540.440 Why?
Intestinal Diseases120185050.430 Why?
Phosphopyruvate Hydratase120131280.430 Why?
Bile Duct Neoplasms320246150.420 Why?
Small Cell Lung Carcinoma220194540.410 Why?
Sarcoidosis120185350.410 Why?
Liver Diseases1202113050.400 Why?
Translocation, Genetic2202113950.390 Why?
Central Nervous System1201813460.370 Why?
Urinary Bladder Neoplasms1202322510.360 Why?
Prognosis162022300460.340 Why?
Tumor Microenvironment1202139520.300 Why?
Medical Oncology1201923500.280 Why?
Humans6520247689700.270 Why?
Patient Selection1201842650.260 Why?
Receptors, Cell Surface1201528200.250 Why?
Liver1202175780.240 Why?
Cell Transformation, Neoplastic1201328480.220 Why?
Antineoplastic Combined Chemotherapy Protocols42023118860.210 Why?
Quinoxalines120242970.200 Why?
Molecular Targeted Therapy4202428300.190 Why?
Morpholines120245840.190 Why?
Antibodies, Monoclonal1201892640.190 Why?
Biliary Tract Neoplasms120221870.180 Why?
Receptors, OX4012020460.170 Why?
Italy220198560.170 Why?
Thymus Neoplasms120222770.170 Why?
Survival Analysis42024101150.170 Why?
Male2520243652030.170 Why?
Neoplasm Metastasis4201849260.160 Why?
Middle Aged2020242237370.160 Why?
Treatment Outcome122024654800.160 Why?
Killer Cells, Natural2201822110.160 Why?
Class I Phosphatidylinositol 3-Kinases120239060.160 Why?
Neoplasm Staging52024112620.160 Why?
Disease Progression52020136740.160 Why?
Female2620243975150.160 Why?
Tumor Escape120213720.150 Why?
Neoplasms, Glandular and Epithelial120224890.150 Why?
Pyrroles1202411250.150 Why?
Indazoles220173060.150 Why?
Portal Vein120214350.150 Why?
Aged1620241717860.150 Why?
BRCA1 Protein1202411560.140 Why?
Pneumonectomy1202411590.140 Why?
Neoplasms32024223890.140 Why?
Lymphocyte Subsets120183130.140 Why?
Proto-Oncogene Proteins p21(ras)3202217690.140 Why?
HLA-A2 Antigen120172080.140 Why?
Oncogene Fusion12017840.140 Why?
Patients120239080.140 Why?
Intubation, Gastrointestinal120181660.140 Why?
Cell Line, Tumor32024171730.130 Why?
Adenocarcinoma1201364010.130 Why?
Germ-Line Mutation1202418870.130 Why?
Exons2202223950.130 Why?
Antifibrinolytic Agents120192890.130 Why?
Clinical Trials, Phase III as Topic120198780.120 Why?
Membrane Proteins3202178850.120 Why?
DNA, Neoplasm1202017480.120 Why?
Disease Susceptibility1202117940.120 Why?
TOR Serine-Threonine Kinases1202320630.120 Why?
Diagnosis, Differential22021130210.110 Why?
Aged, 80 and over102024597390.110 Why?
Leukocyte Count1201816090.110 Why?
Salvage Therapy1202112770.110 Why?
Fatal Outcome1201918360.110 Why?
Phosphatidylinositol 3-Kinases1202328840.110 Why?
Anilides120174140.110 Why?
Drug Substitution120162910.110 Why?
Clinical Trials as Topic2201980550.110 Why?
Adult1620242238510.100 Why?
Oncogene Proteins, Fusion2202116160.100 Why?
Molecular Diagnostic Techniques120176200.100 Why?
Randomized Controlled Trials as Topic22019104000.100 Why?
Quinazolines2201713730.100 Why?
Enteral Nutrition120188020.100 Why?
Drug Therapy, Combination2201963200.090 Why?
Benzamides1201713870.090 Why?
Disease-Free Survival3201968560.090 Why?
Neoplasm Recurrence, Local3202494420.090 Why?
Disease Management1202125370.090 Why?
Energy Metabolism1202129050.090 Why?
Osteoblasts1201511530.080 Why?
Kaplan-Meier Estimate2201765470.080 Why?
Carcinoma, Renal Cell2201632000.080 Why?
Prospective Studies52021549620.080 Why?
Intracellular Signaling Peptides and Proteins1201928930.080 Why?
Signal Transduction32021236530.080 Why?
Lung Diseases, Interstitial120179400.080 Why?
Angiogenesis Inhibitors2201620590.080 Why?
Retrospective Studies82022819030.080 Why?
Kidney Neoplasms2201643000.070 Why?
Bone Neoplasms1202025650.070 Why?
Mice, SCID2202426310.070 Why?
Piperazines1201725530.070 Why?
Anti-Bacterial Agents2202274780.060 Why?
Venous Thromboembolism1201918810.060 Why?
Sulfonamides1201619810.060 Why?
Pneumonia1201721640.060 Why?
Health Personnel1201933830.060 Why?
Gene Expression Regulation, Neoplastic1202186640.060 Why?
Early Detection of Cancer2202132380.060 Why?
CD8-Positive T-Lymphocytes1201846510.060 Why?
Animals420241693350.060 Why?
Follow-Up Studies32020393940.060 Why?
Rad51 Recombinase120241910.050 Why?
Kidney Failure, Chronic1201624930.050 Why?
Immunohistochemistry12016111160.050 Why?
Mice32024820720.050 Why?
Platinum120222220.050 Why?
Clinical Trials, Phase I as Topic120223300.050 Why?
Thymoma120221910.050 Why?
High-Throughput Nucleotide Sequencing2202436710.050 Why?
Calmodulin-Binding Proteins120212390.040 Why?
Clinical Trials, Phase II as Topic120226400.040 Why?
Benzodiazepinones12019500.040 Why?
Neurofibromin 2120192710.040 Why?
Betamethasone12017480.040 Why?
Microtubule-Associated Proteins1202210740.030 Why?
Organophosphorus Compounds120172110.030 Why?
Ligands1202332830.030 Why?
Tomography, X-Ray Computed22016207760.030 Why?
Mice, Inbred NOD1201918390.030 Why?
In Situ Hybridization, Fluorescence1202125250.030 Why?
Half-Life120166510.030 Why?
Epithelial-Mesenchymal Transition120197550.030 Why?
Receptors, Notch120197510.030 Why?
China1202023950.030 Why?
United States Food and Drug Administration1202216720.030 Why?
Withholding Treatment120176200.030 Why?
Lung22021100990.020 Why?
Immunoconjugates120199760.020 Why?
Length of Stay1202465260.020 Why?
Nerve Tissue Proteins1202144130.020 Why?
Young Adult32022601310.020 Why?
Flow Cytometry1201859060.020 Why?
DNA1202272140.020 Why?
Diarrhea1201413200.020 Why?
Renal Dialysis1201617890.020 Why?
Survival Rate12020128730.020 Why?
Body Mass Index12022130550.010 Why?
Receptor, erbB-21201426060.010 Why?
Dose-Response Relationship, Drug12016107650.010 Why?
Longitudinal Studies12019147940.010 Why?
Coronavirus Infections1202031180.010 Why?
Pneumonia, Viral1202032410.010 Why?
Postoperative Complications12024158890.010 Why?
Polymorphism, Single Nucleotide12021160530.010 Why?
Pandemics1202087490.010 Why?
Cytokines1201374530.010 Why?
Cohort Studies12017418080.010 Why?
United States12022731860.010 Why?
Risk Factors12019749760.010 Why?
Facchinetti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (186)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.